|
|
| (No se muestran 90 ediciones intermedias de 11 usuarios) |
| Línea 1: |
Línea 1: |
| == General == | | {{PediatricPage|seizure}} |
| | ==Background== |
| | {{Seizure types}} |
| | {{Clinical features seizure}} |
|
| |
|
| It is important to consider performing imaging in young patients with new-onset focal seizures to look for a brain mass or trauma
| | ==Differential Diagnosis== |
| | {{Pediatric seizure DDX}} |
|
| |
|
| immed after trauma = impact sz (no antieleptics)
| | ==Evaluation== |
| | ===Seizure with a Fever=== |
| | *See [[Febrile Seizure]] |
|
| |
|
| >20min after = TBI (antieleptic)
| | ===[[first-time seizure|First-Time Afebrile Seizure]]=== |
| | *If patient returns to baseline no labs/imaging necessarily indicated |
| | **Head to toe exam - abusive head trauma may precipitate seizure and requires emergent imaging |
| | **Glucose |
| | **Consider chemistry, Mg |
| | **Consider [[EKG]] if concerned for cardiac [[arrhythmia]] |
| | *[[LP]] only necessary if concern for [[meningitis (peds)]] |
| | *Neuroimaging |
| | **Preferred test is outpatient [[brain MRI|MRI]] |
| | **Consider emergent imaging ([[CT head]]) for [[focal neuro|focal deficit]], no return to baseline |
| | *40% have 2nd seizure |
|
| |
|
| INH --> pyridoxine
| | ===Neonatal Seizure=== |
| | *Often subtle, focal, poor prognosis |
| | **Less often have generalized tonic-clonic seizures |
| | ***Findings include lip smacking, eye deviation, staring, [[ALTE]] |
| | *Work-up |
| | **CBC, chemistry, [[UA]], [[LP]] for CSF (including HSV), utox (withdrawal) |
| | **Consider neuroimaging if concern for abuse, [[intracranial hemorrhage]], mass |
| | **Consider [[lactate]], ammonia if concern for [[inborn errors of metabolism]] |
| | *Treatment |
| | **Start IV [[pediatric antibiotics|antimicrobials]] (including [[acyclovir]]) |
| | **Phenobarbital is first-line treatment for most neonatal seizures <ref> Shellhaas, R. Treatment of neonatal seizures. In: UpToDate, Post TW (Ed), Wolters Kluwer. https://www.uptodate.com (Accessed on October 28, 2023.) </ref> |
| | **Consider [[pyridoxine]] and [[folic acid]] if unresponsive to treatment<ref>Robert Surtees and Nicole Wolf. Treatable neonatal epilepsy. Arch Dis Child. 2007 Aug; 92(8): 659–661.</ref> |
| | ***Pyridoxal phosphate 10mg/kg/dose q2h x 2 doses |
| | ***If persistent, folinic acid 5mg q6h x 2 doses |
| | ***EEG monitoring during this period is helpful |
|
| |
|
| Status epilepticus is a "prolonged" seizure or recurrent seizures lasting >5 minutes without the patient's regaining consciousness. Rapid cessation of status epilepticus is important to prevent irreversible neuronal damage
| | ===Epileptic Seizures=== |
| | *Epilepsy = 2 or more seizures with out acute provocation (fever, trauma) |
| | *Often due to patient "outgrowing" their dosage |
| | *Check levels: |
| | **See [[anticonvulsant levels and reloading]] |
| | **[[Phenytoin]], [[carbamazepine]], [[valproic acid]] |
| | ***If low consider medication non-adherence, "outgrowing" dose, vomiting, med interaction |
| | *Patients with epilepsy may have lower seizure threshold with febrile illness |
| | **Usually can limit ED work up to fever evaluation |
|
| |
|
| In children with a prolonged postictal state, especially in those who are not known to have had a prolonged postictal state with past epileptic episodes, consider the diagnosis of nonconvulsive status epilepticus.8 Consider an emergency EEG to identify seizure activity. If EEG testing is not available, a trial of anticonvulsants can be initiated and might result in improved mental status. Morbidity and mortality are increased when nonconvulsive status epilepticus is untreated, but less so than with untreated convulsive status epilepticus.8
| | ===Seizure with [[VP shunt]]=== |
| | *Consider underlying epilepsy, [[VP shunt malfunction|shunt malfunction]], [[VP shunt infections|CNS infection]] |
| | **If patient has fever, seizure more likely secondary to infection than malfunction |
| | ***Consult pediatric neurosurgeon to tap the shunt |
| | *Imaging |
| | **Obtain shunt series and [[head CT]] or [[brain MRI|MRI]] to evaluate for increased ventricular size |
|
| |
|
| Events Masquerading as Seizures
| | ===Seizure with [[Pediatric Head Trauma]]=== |
| | *"Impact seizures" (seizures that occurs within minutes of head trauma) |
| | **Not associated with severe head injuries |
| | *Seizures that occur after this time more likely to represent intracranial injury |
| | *Abusive head trauma should always be considered in differential |
|
| |
|
| {| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif;"
| | ===[[Status Epilepticus]]=== |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | *Seizure or recurrent seizure lasting >5min with out regaining consciousness |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | '''Syncope'''
| | **If prolonged postictal state or longer than usual consider nonconvulsive status |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | ***Obtain emergency EEG; if not available, trial of anticonvulsants appropriate |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | '''Breath-holding spells'''
| | *Management |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | **Glucose, chemistry, CBC, [[LFTs]], ?CSF, ?neuroimaging |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Cataplexy
| | **[[Intubate]] if evidence of apnea and persistent hypoxia |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | **If paralytic used, EEG monitoring should be arranged |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Narcolepsy
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | '''Vasovagal event'''
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Standing for long periods of time
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Standing quickly from laying or sitting
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Hair-grooming syncope
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Earring-changing syncope
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Micturition syncope
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Emotional distress or pain
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | '''Hypoglycemia'''
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | '''Hypovolemia'''
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Sandifer syndrome (gastroesophageal reflux)
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Acute life-threatening event
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Acute dystonic reactions/drug reactions [i.e., promethazine (Phenergan)]
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Movement disorders
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Tics
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Myoclonic jerks
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Chills or rigors
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Shudder attacks
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Mannerisms
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Self-stimulation
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Choreoathetosis
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Night terrors, sleep walking
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Migraine variants
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Benign paroxysmal vertigo
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | '''Nonepileptic paroxysmal event (pseudoseizure)'''
| |
| |}
| |
|
| |
|
| In one study, lateral tongue biting was found to have a specificity of 100% and a sensitivity of 24% for the occurrence of a seizure.11
| | ==Management== |
| | {{Initial management of pediatric status epilepticus}} |
|
| |
|
| Seizure with a fever can be associated with central nervous system (CNS) infection (meningitis, encephalitis, or abscess), especially in very young patients. More commonly, however, fever simply lowers the seizure threshold in patients with epilepsy or causes a simple febrile seizure. A patient with new-onset afebrile seizures may require a more thorough evaluation than patients with epilepsy taking anticonvulsant medications, who may just have "outgrown" their dosage. A seizure associated with a "breath-holding spell" is usually a benign event. Postimpact seizures occur immediately after head trauma and do not often indicate significant brain injury. However, new-onset seizures that occur more remotely after head trauma may be more ominous and signal severe head trauma. Sometimes a seizure's underlying cause is not discovered, and the seizure is labeled idiopathic
| | ===[[Hypoglycemia (Peds)|Hypoglycemia]]=== |
| | *Defined as <50mg/dL |
| | *All seizing patients with hypoglycemia should be treated with 2 mL/kg 25% dextrose |
|
| |
|
| Todd paralysis is a temporary condition characterized by a focal deficit of unknown etiology that can last up to 36 hours after a seizure.12 The paralysis is usually unilateral and lasts on average 15 hours.12 However, it can be bilateral and involve a patient's speech or vision.12 It may be impossible to distinguish Todd paralysis from stroke, and emergent evaluation for a stroke should still be considered.12
| | ===[[Hyponatremia]]=== |
| | *Consider as cause of seizure, especially if Na <120 mEq/L |
| | *Goal of therapy is to correct quickly to >120, slowly thereafter |
| | **In actively seizing patient, treatment of choice is [[hypertonic saline|3% NaCl]] |
| | ***[[hypertonic saline|3% NaCl]] (513 mEq/1000 mL) |
| | ****Na deficit in total mEq = [(wt in kg)x(130 – serum Na level)x0.6] over 20min '''OR''' |
| | ***3% NaCl: 4-6 mL/kg over 20min |
| | **If no seizure activity but Na <120 start 4-6 mL/kg 3% NaCl or 20 mL/kg of NS over 1hr |
| | ***Check Na level after bolus to see if second bolus is necessary |
| | **If 3% unavailable, start NS 20mL/kg |
|
| |
|
| Rapid bedside testing for electrolyte levels (glucose, sodium, and calcium) is recommended in status epilepticus when available.4,7 Order a complete blood count (CBC), full chemistry panel, hepatic and renal studies, and anticonvulsant levels, if appropriate, when an IV is placed. Other studies may be needed depending upon the suspected underlying cause of seizures. Consider CNS infection in the child with fever and status epilepticus.
| | ===[[Hypocalcemia]]=== |
| | *Administer 10% [[calcium gluconate]] 0.3 mL/kg over 5-10min |
|
| |
|
| he decision to intubate is clinical. Intubate for apnea and persistent hypoxia. Blood gas concentrations are not needed to guide the decision to intubate, because the seizure itself causes a metabolic and respiratory acidosis. The use of a paralytic with intubation will obscure the ability to assess ongoing seizure activity, and continuous EEG monitoring should be arranged for intubated patients with status epilepticus.
| | ===Other=== |
| | *Consider [[Pyridoxine]] (vitamin B6) 1g per g of [[INH]] ingested (in D5W IV over 30 min) <ref> Minns AB, Ghafouri N, Clark RF. Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy. Pediatr Emerg Care. 2010; 26(5):380-1. </ref> |
| | *Consider Pyridoxine Responsive Seizure Disorder - 100mg/pyridoxine is generally effective <ref>Pyridoxine dependent seizures a wider clinical spectrum. Archives of Disease in Childhood.1983 (58) 415-418. http://adc.bmj.com/content/58/6/415.full.pdf</ref> |
|
| |
|
| For these reasons, initial benzodiazepine treatment should be limited to two doses.
| | {{Pediatric anticonvulsants}} |
|
| |
|
|
| |
|
| | ==Medication Dosing== |
| | {{MedicationDose |
| | | drug = Dextrose |
| | | dose = 2mL/kg of D25W |
| | | route = IV |
| | | context = Hypoglycemic seizure (glucose <50mg/dL) |
| | | indication = Seizure (peds) |
| | | population = Pediatric |
| | }} |
| | {{MedicationDose |
| | | drug = Hypertonic saline |
| | | dose = 4-6mL/kg of 3% NaCl over 20min |
| | | route = IV |
| | | context = Hyponatremic seizure |
| | | indication = Seizure (peds) |
| | | population = Pediatric |
| | }} |
| | {{MedicationDose |
| | | drug = Calcium gluconate |
| | | dose = 0.3mL/kg of 10% solution over 5-10min |
| | | route = IV |
| | | context = Hypocalcemic seizure |
| | | indication = Seizure (peds) |
| | | population = Pediatric |
| | }} |
| | {{MedicationDose |
| | | drug = Pyridoxine |
| | | dose = 100mg |
| | | route = IV |
| | | context = Pyridoxine-responsive seizure disorder |
| | | indication = Seizure (peds) |
| | | population = Pediatric |
| | }} |
|
| |
|
| {| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif;"
| | ==Disposition== |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| | If negative workup |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Drug
| | *EEG and MRI as outpatient |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Route
| | *Diastat ([[diazepam]]) Rectal Kit |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Dose*
| | **2-5 yrs: 0.5mg/kg |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Maximum
| | **6-11 yrs: 0.3mg/kg |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Onset of Action
| | **12+ yrs: 0.2mg/kg |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Duration of Action
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Lorazepam
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | IV, IO, IN<sup>[[Image:]]</sup><br/>
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 0.1 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 4 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 1–5 min
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 12–24 h
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | IM
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 0.1 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 4 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 15–30 min
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 12–24 h
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="2" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Diazepam
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | IV, IO
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 0.1–0.3 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 10 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 1–5 min
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 15–60 min
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | PR
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 0.5 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 20 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 3–5 min
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 15–60 min
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" rowspan="4" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Midazolam
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | IV, IO
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 0.1–0.2 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 4 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 1–5 min
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 1–6 h
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | IM
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 0.2 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 10 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 5–15 min
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 1–6 h
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | IN
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 0.2 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 10 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 1–5 min
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 1–6 h
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | Buccal<sup>[[Image:]]</sup><br/>
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 0.5 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 10 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 3–5 min
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | 1–6 h
| |
| |}
| |
|
| |
|
| <br/>If a seizure persists for another 5 minutes after two doses of a benzodiazepine have been given, fosphenytoin or phenobarbital are the preferred second-line treatment choices
| | ==See Also== |
| | *[[Seizure]] |
| | *[[Febrile Seizure]] |
| | *[[Seizure Levels and Reloading]] |
| | *[[Status epilepticus (peds)]] |
|
| |
|
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; line-height: 19px; ">Fosphenytoin is usually the preferred second-line treatment over phenobarbital, mainly because it differs from the benzodiazepines</span>
| | ==External Links== |
| | *[http://pemplaybook.org/podcast/131/ Pediatric Emergency Playbook Podcast - Carpe Cerebrum: Seize the Brain] |
| | **[http://traffic.libsyn.com/pemplaybook/Pediatric_Status_Epilepticus.mp3 Carpe Cerebrum: Seize the Brain (mp3)] |
|
| |
|
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; line-height: 19px; ">'''Phenobarbital is preferred over phenytoin or fosphenytoin in children who have allergies to fosphenytoin or phenytoin, present with a febrile illness, or are <2 years of age. Side effects of phenobarbital are sedation and cardiorespiratory depression, which may be amplified by benzodiazepines'''</span>
| | ==References== |
| | <references/> |
|
| |
|
| | | [[Category:Pediatrics]] |
| | | [[Category:Neurology]] |
| | |
| {| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; "
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Drug
| |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Route
| |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Loading Dose
| |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Repeat Dose
| |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | Maximum
| |
| ! valign="top" bgcolor="#ffffff" align="left" rowspan="0" | IV Infusion
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Fosphenytoin
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | IV, IM
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 15–20 milligrams/kg PE
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5–10 milligrams/kg PE
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 30 milligrams/kg PE
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3 milligrams/kg/min PE
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Phenobarbital
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | IV
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 15–20 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5–10 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 40 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 1–30 milligrams/min
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Valproic acid
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | IV
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 20 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 15–20 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 40 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5 milligrams/kg/h
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Levetiracetam
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | IV
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 20–30 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | —
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 3 grams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | —
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Pentobarbital
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | IV
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5–15 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 1–2 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 15 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 0.5–5.0 milligrams/kg/h
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Propofol
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | IV
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 0.5–2.0 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 0.5–1.0 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 5 milligrams/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 1.5–4.0 milligrams/kg/h
| |
| |- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; "
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | Midazolam
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | IV
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 0.1–0.2 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 0.1–0.2 milligram/kg
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 10 milligrams
| |
| | valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px; " | 0.05–0.4 milligram/kg/h
| |
| |}
| |
| | |
| | |
| | |
| | |
| Third-Line Treatment
| |
| | |
| One study showed seizure termination within 30 minutes in all 18 children who received a loading dose of 25 milligrams/kg IV
| |
| | |
| In another study 41 patients were treated with valproic acid 20 to 40 milligrams/kg IV over 1 to 5 minutes and then received an infusion of 5 milligrams/kg/h of valproic acid. This study showed clinically and EEG determined termination of seizures in 78% of patients, in 66% within 6 minutes
| |
| | |
| | |
| | |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; line-height: 19px; ">Hypoglycemia is defined as a glucose level of <50 milligrams/dL regardless of whether symptoms exist. There are multiple causes of hypoglycemia, but the most common cause in children is decreased intake of glucose. Seizures can occur with hypoglycemia, so glucose level should be measured in all patients presenting with seizures. If hypoglycemia is present, patients should be treated with a rapid infusion of 2 mL/kg of 25% dextrose in water.</span>
| |
| | |
| | |
| HYPONATREMIA
| |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; " />
| |
| Excessive water drinking can lead to hyponatremia (<135 mEq/L). Hyponatremia is most commonly seen in infants <6 months of age and sometimes in athletes. Babies who drink several bottles of water a day or who drink dilute infant formula are at risk for hyponatremia. Athletes can also suffer from water intoxication.
| |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; " />
| |
| Hyponatremia can cause seizures, especially if the sodium level is <120 mEq/L. The goal of therapy is to correct the level to >120 mEq/L quickly to treat or prevent further seizure activity, and then correct the sodium to normal levels over the next 24 hours (see Chapter 142, Fluid and Electrolyte Therapy in Infants and Children).<sup>6</sup> If a patient is actively experiencing seizure, the treatment of choice is 3% NaCl.<sup>6</sup> An infusion of 20 mL/kg of 0.9% NaCl should be started immediately for patients in status epilepticus if delivery of 3% NaCl is delayed. The calculation for 3% NaCl is presented in '''Formula 129-1'''.
| |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; " />
| |
| Formula 129-1
| |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; " />
| |
| Rapid correction of hyponatremia in pediatric status epilepticus.
| |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; " />
| |
| 3% NaCl (513 mEq/1000 mL): Na deficit in total mEq = [(weight in kg) <small>x</small> (130 – serum Na level) <small>x</small> 0.6] over 20 minutes
| |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; " />
| |
| ''or''
| |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; " />
| |
| 3% NaCl: 4 to 6 mL/kg over 20 minutes
| |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; " />
| |
| If there is no seizure activity but the sodium level is below 120 mEq/L, 4 to 6 mL/kg of 3% NaCl or 20 mL/kg of normal saline can be given over an hour. The sodium level should be rechecked after the bolus to see if a second bolus is necessary.<sup>6</sup>
| |
| | |
| | |
| | |
| | |
| <span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; line-height: 19px; ">As with other electrolyte abnormalities, the hypocalcemia must be addressed by administration of calcium in order to treat seizures, because benzodiazepines are not very effective in this setting. Ten percent calcium gluconate (0.3 mL/kg administered slowly over 5 to 10 minutes) is the preferred type of IV calcium, because calcium chloride often causes local irritation.</span><span class="Apple-style-span" style="color: rgb(51, 51, 51); font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 12px; line-height: 19px; "><sup>6</sup></span>
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| [[Category:Peds]] <br/> | |